Active secondary progressive multiple sclerosis treatment with a selective sphingosine-1-phosphate receptor modulator

被引：0
|
作者：
Michnova, Katerina [1 ]
Horakova, Dana [2 ]
机构：
[1] Care Comm Sro, Prague, Czech Republic
[2] 1 LF UK VFN Praze, Neurol Klin, Prague, Czech Republic
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2020年 / 83卷 / 06期
关键词：
INTERFERON BETA-1B; MS;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：683 / 684
页数：2
相关论文
共 50 条
  • [1] Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis
    Giancarlo Comi
    Hans-Peter Hartung
    Rajesh Bakshi
    Ian M. Williams
    Heinz Wiendl
    [J]. Drugs, 2017, 77 : 1755 - 1768
  • [2] Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Bakshi, Rajesh
    Williams, Ian M.
    Wiendl, Heinz
    [J]. DRUGS, 2017, 77 (16) : 1755 - 1768
  • [3] An oral sphingosine 1-phosphate receptor modulator for the treatment of multiple sclerosis
    不详
    [J]. FORMULARY, 2010, 45 (11) : 335 - 335
  • [4] Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
    Musella, Alessandra
    Gentile, Antonietta
    Guadalupi, Livia
    Rizzo, Francesca Romana
    De Vito, Francesca
    Fresegna, Diego
    Bruno, Antonio
    Dolcetti, Ettore
    Vanni, Valentina
    Vitiello, Laura
    Bullitta, Silvia
    Sanna, Krizia
    Caioli, Silvia
    Balletta, Sara
    Nencini, Monica
    Buttari, Fabio
    Bassi, Mario Stampanoni
    Centonze, Diego
    Mandolesi, Georgia
    [J]. CELLS, 2020, 9 (05)
  • [5] Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis
    Choi, David
    Becker, Michelle
    Ivanov, Marina
    Bhat, Shubha
    [J]. ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 1054 - 1063
  • [6] Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis
    Mowry, Ellen M.
    Corboy, John R.
    [J]. LANCET NEUROLOGY, 2019, 18 (11): : 983 - 985
  • [7] Ponesimod: An Oral Second-Generation Selective Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Multiple Sclerosis
    Alnaif, Amal
    Oiler, Isabelle
    D'Souza, Manoranjan S.
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (08) : 956 - 965
  • [8] PRECLINICAL AND CLINICAL CHARACTERIZATION OF CENERIMOD, A POTENT, SELECTIVE, AND ORALLY ACTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 MODULATOR IN SLE
    Strasser, D.
    Gerossier, E.
    Sippel, V.
    Grieder, U.
    Kieninger, A.
    Pierlot, G.
    Farine, H.
    Kulig, P.
    Keller, M.
    Froidevaux, S.
    Trendelenburg, M.
    Martinic, M.
    Murphy, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1019 - 1019
  • [9] Sphingosine-1-phosphate and oligodendrocytes: From cell development to the treatment of multiple sclerosis
    Coelho, Rochelle P.
    Saini, Harsimran S.
    Sato-Bigbee, Carmen
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2010, 91 (3-4) : 139 - 144
  • [10] BAF312, a Selective Sphingosine-1-Phosphate Receptor Modulator Improves MRI and Clinical Outcomes in Relapsing-Remitting Multiple Sclerosis (RRMS)
    Stuve, Olaf
    Selmaj, Krzysztof
    Li, David
    Hartung, Hans-Peter
    Hemmer, Bernhard
    Kappos, Ludwig
    Freedman, Mark
    Rieckmann, Peter
    Montalban, Xavier
    Auberson, Lixin Zhang
    Pohlmann, Harald
    Mercier, Francois
    Dahlke, Frank
    Wallstrom, Erik
    [J]. NEUROLOGY, 2012, 78
12345